Immunic Historical Balance Sheet

IMUX Stock

USD 1.10 0.01 0.90%

Trend analysis of Immunic balance sheet accounts such as Other Current Liabilities of 19.9 M or Total Current Liabilities of 26 M provides information on Immunic's total assets, liabilities, and equity, which is the actual value of Immunic to its prevalent stockholders. By breaking down trends over time using Immunic balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Immunic latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Immunic is a good buy for the upcoming year.

Immunic Inventory

(2.27 Million)

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

For more information on how to buy Immunic Stock please use our How to Invest in Immunic guide.

About Immunic Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Immunic at a specified time, usually calculated after every quarter, six months, or one year. Immunic Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Immunic and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Immunic currently owns. An asset can also be divided into two categories, current and non-current.

Immunic Balance Sheet Chart

At this time, Immunic's Short Term Debt is fairly stable compared to the past year. Non Current Liabilities Other is likely to rise to about 1.2 M in 2024, whereas Short and Long Term Debt Total is likely to drop slightly above 955.9 K in 2024.

Total Assets Other Current Liab Total Current Liabilities Good Will Net Working Capital

Add Fundamental

Total Assets

Total assets refers to the total amount of Immunic assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Immunic books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Immunic balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Immunic are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Good Will

An intangible asset that arises when a company acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors.

Most accounts from Immunic's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Immunic current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

For more information on how to buy Immunic Stock please use our How to Invest in Immunic guide.At this time, Immunic's Short Term Debt is fairly stable compared to the past year. Non Current Liabilities Other is likely to rise to about 1.2 M in 2024, whereas Short and Long Term Debt Total is likely to drop slightly above 955.9 K in 2024.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	584K	1.6M	1.3M	955.9K
Total Assets	139.1M	127.8M	54.3M	81.3M

Short Long Term Debt Total Total Assets

Immunic balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Short Term Investments	Non Currrent Assets Other	Common Stock Total Equity	Common Stock	Net Tangible Assets	Retained Earnings Total Equity
Total Assets		0.31	0.32	0.39	0.96	0.21	-0.95	-0.04	0.57	0.96	0.6	0.96	0.41	-0.62	0.7	0.33	-0.53	0.21	0.97	-0.23	-0.48	-0.53	0.28	0.28	0.34	0.05
Short Long Term Debt Total	0.31		0.62	0.69	0.21	-0.04	-0.31	-0.58	0.2	0.34	-0.16	0.37	0.82	-0.22	0.4	0.56	0.05	-0.04	0.39	-0.03	0.06	-0.45	0.56	0.56	0.47	-0.51
Other Current Liab	0.32	0.62		0.97	0.22	0.23	-0.33	-0.62	0.43	0.4	-0.19	0.39	0.82	-0.45	0.32	0.46	-0.09	0.23	0.4	-0.2	-0.43	-0.47	0.64	0.65	0.3	-0.57
Total Current Liabilities	0.39	0.69	0.97		0.27	0.09	-0.34	-0.6	0.39	0.41	0.0	0.4	0.91	-0.46	0.42	0.45	-0.08	0.09	0.42	-0.07	-0.42	-0.56	0.57	0.58	0.31	-0.46
Total Stockholder Equity	0.96	0.21	0.22	0.27		0.28	-0.94	-0.04	0.55	0.93	0.59	0.92	0.26	-0.75	0.64	0.38	-0.73	0.28	0.93	-0.14	-0.6	-0.55	0.33	0.32	0.18	0.03
Property Plant And Equipment Net	0.21	-0.04	0.23	0.09	0.28		-0.43	0.06	0.67	0.42	-0.38	0.41	-0.19	-0.34	-0.15	0.04	-0.35	1.0	0.37	-0.58	-0.32	0.24	0.19	0.19	0.17	-0.11
Net Debt	-0.95	-0.31	-0.33	-0.34	-0.94	-0.43		0.03	-0.68	-0.99	-0.39	-0.99	-0.29	0.63	-0.55	-0.34	0.56	-0.43	-0.98	0.34	0.49	0.44	-0.36	-0.36	-0.36	0.05
Retained Earnings	-0.04	-0.58	-0.62	-0.6	-0.04	0.06	0.03		0.13	-0.07	0.24	-0.07	-0.64	0.4	-0.23	-0.88	0.19	0.06	-0.09	-0.15	0.3	0.64	-0.83	-0.84	0.12	0.86
Accounts Payable	0.57	0.2	0.43	0.39	0.55	0.67	-0.68	0.13		0.69	0.03	0.67	0.21	-0.44	0.2	-0.03	-0.33	0.67	0.65	-0.33	-0.41	-0.18	0.24	0.24	0.3	0.01
Cash	0.96	0.34	0.4	0.41	0.93	0.42	-0.99	-0.07	0.69		0.38	0.99	0.36	-0.64	0.55	0.35	-0.54	0.42	0.99	-0.34	-0.5	-0.47	0.38	0.38	0.36	-0.08
Non Current Assets Total	0.6	-0.16	-0.19	0.0	0.59	-0.38	-0.39	0.24	0.03	0.38		0.35	0.12	-0.27	0.57	0.02	-0.3	-0.38	0.39	0.27	-0.33	-0.43	-0.19	-0.2	-0.03	0.53
Cash And Short Term Investments	0.96	0.37	0.39	0.4	0.92	0.41	-0.99	-0.07	0.67	0.99	0.35		0.37	-0.63	0.56	0.35	-0.53	0.41	1.0	-0.36	-0.44	-0.45	0.37	0.37	0.38	-0.09
Common Stock Shares Outstanding	0.41	0.82	0.82	0.91	0.26	-0.19	-0.29	-0.64	0.21	0.36	0.12	0.37		-0.33	0.58	0.53	0.03	-0.19	0.4	0.03	-0.2	-0.62	0.51	0.52	0.39	-0.43
Non Current Liabilities Total	-0.62	-0.22	-0.45	-0.46	-0.75	-0.34	0.63	0.4	-0.44	-0.64	-0.27	-0.63	-0.33		-0.38	-0.55	0.92	-0.34	-0.63	-0.12	0.87	0.67	-0.56	-0.57	0.2	0.32
Other Current Assets	0.7	0.4	0.32	0.42	0.64	-0.15	-0.55	-0.23	0.2	0.55	0.57	0.56	0.58	-0.38		0.44	-0.25	-0.15	0.63	-0.09	-0.26	-0.5	0.31	0.31	0.34	-0.11
Other Stockholder Equity	0.33	0.56	0.46	0.45	0.38	0.04	-0.34	-0.88	-0.03	0.35	0.02	0.35	0.53	-0.55	0.44		-0.42	0.04	0.38	0.04	-0.39	-0.7	0.86	0.86	0.0	-0.73
Total Liab	-0.53	0.05	-0.09	-0.08	-0.73	-0.35	0.56	0.19	-0.33	-0.54	-0.3	-0.53	0.03	0.92	-0.25	-0.42		-0.35	-0.52	-0.16	0.79	0.51	-0.39	-0.38	0.36	0.16
Property Plant And Equipment Gross	0.21	-0.04	0.23	0.09	0.28	1.0	-0.43	0.06	0.67	0.42	-0.38	0.41	-0.19	-0.34	-0.15	0.04	-0.35		0.37	-0.58	-0.32	0.24	0.19	0.19	0.17	-0.11
Total Current Assets	0.97	0.39	0.4	0.42	0.93	0.37	-0.98	-0.09	0.65	0.99	0.39	1.0	0.4	-0.63	0.63	0.38	-0.52	0.37		-0.35	-0.45	-0.47	0.37	0.38	0.4	-0.09
Short Term Debt	-0.23	-0.03	-0.2	-0.07	-0.14	-0.58	0.34	-0.15	-0.33	-0.34	0.27	-0.36	0.03	-0.12	-0.09	0.04	-0.16	-0.58	-0.35		-0.17	-0.43	0.05	0.06	-0.68	-0.04
Short Term Investments	-0.48	0.06	-0.43	-0.42	-0.6	-0.32	0.49	0.3	-0.41	-0.5	-0.33	-0.44	-0.2	0.87	-0.26	-0.39	0.79	-0.32	-0.45	-0.17		0.59	-0.45	-0.45	0.3	0.18
Non Currrent Assets Other	-0.53	-0.45	-0.47	-0.56	-0.55	0.24	0.44	0.64	-0.18	-0.47	-0.43	-0.45	-0.62	0.67	-0.5	-0.7	0.51	0.24	-0.47	-0.43	0.59		-0.68	-0.69	0.24	0.45
Common Stock Total Equity	0.28	0.56	0.64	0.57	0.33	0.19	-0.36	-0.83	0.24	0.38	-0.19	0.37	0.51	-0.56	0.31	0.86	-0.39	0.19	0.37	0.05	-0.45	-0.68		1.0	-0.08	-0.87
Common Stock	0.28	0.56	0.65	0.58	0.32	0.19	-0.36	-0.84	0.24	0.38	-0.2	0.37	0.52	-0.57	0.31	0.86	-0.38	0.19	0.38	0.06	-0.45	-0.69	1.0		-0.08	-0.87
Net Tangible Assets	0.34	0.47	0.3	0.31	0.18	0.17	-0.36	0.12	0.3	0.36	-0.03	0.38	0.39	0.2	0.34	0.0	0.36	0.17	0.4	-0.68	0.3	0.24	-0.08	-0.08		0.15
Retained Earnings Total Equity	0.05	-0.51	-0.57	-0.46	0.03	-0.11	0.05	0.86	0.01	-0.08	0.53	-0.09	-0.43	0.32	-0.11	-0.73	0.16	-0.11	-0.09	-0.04	0.18	0.45	-0.87	-0.87	0.15

Click cells to compare fundamentals

Immunic Account Relationship Matchups

Immunic balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	66.0M	167.9M	139.1M	127.8M	54.3M	81.3M
Other Current Liab	343K	4.4M	7.2M	8.2M	18.9M	19.9M
Total Current Liabilities	7.1M	8.4M	11.4M	13.1M	24.7M	26.0M
Total Stockholder Equity	58.4M	158.8M	127.1M	113.7M	28.9M	27.5M
Property Plant And Equipment Net	713K	1.1M	1.1M	1.8M	1.8M	1.4M
Net Debt	(28.8M)	(126.8M)	(86.3M)	(105.2M)	(45.3M)	(47.6M)
Retained Earnings	(59.9M)	(103.9M)	(196.9M)	(317.3M)	(410.9M)	(390.3M)
Accounts Payable	2.4M	3.7M	3.7M	4.3M	5.1M	3.9M
Cash	29.4M	127.5M	86.9M	106.7M	46.7M	64.0M
Non Current Assets Total	33.7M	34.1M	34.1M	1.9M	1.8M	1.7M
Cash And Short Term Investments	29.4M	127.5M	86.9M	116.4M	46.7M	66.0M
Common Stock Shares Outstanding	7.7M	15.7M	23.7M	31.8M	44.3M	46.5M
Liabilities And Stockholders Equity	66.0M	167.9M	139.1M	127.8M	54.3M	81.3M
Non Current Liabilities Total	520K	679K	584K	992K	639K	607.1K
Other Current Assets	2.9M	6.3M	18.1M	9.5M	5.9M	4.6M
Other Stockholder Equity	53.7M	266.8M	324.2M	427.9M	436.1M	245.3M
Total Liab	7.6M	9.1M	12.0M	14.1M	25.4M	26.6M
Property Plant And Equipment Gross	713K	1.1M	1.1M	1.8M	1.8M	1.4M
Total Current Assets	32.2M	133.7M	105.0M	125.9M	52.5M	70.8M
Accumulated Other Comprehensive Income	(1.4M)	(4.1M)	(252K)	3.0M	3.8M	3.9M
Non Currrent Assets Other	108K	37K	42K	43K	38.7K	36.8K
Net Tangible Assets	25.4M	125.8M	94.1M	113.7M	130.7M	80.6M
Retained Earnings Total Equity	(59.9M)	(103.9M)	(196.9M)	(317.3M)	(285.6M)	(299.8M)
Capital Surpluse	119.6M	266.8M	324.2M	427.9M	492.1M	326.3M
Non Current Liabilities Other	520K	679K	584K	992K	1.1M	1.2M
Property Plant Equipment	80K	203K	1.1M	294K	264.6K	251.4K
Other Assets	37K	42K	943K	43K	49.5K	47.0K
Net Receivables	408K	1.6M	2.2M	2.7M	703K	1.3M
Net Invested Capital	58.4M	158.8M	127.1M	113.7M	28.9M	27.5M
Net Working Capital	25.2M	125.3M	93.6M	112.8M	27.8M	26.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Immunic Stock Analysis

When running Immunic's price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Immunic Historical Balance Sheet

Immunic Inventory

(2.27 Million)

About Immunic Balance Sheet Analysis

Immunic Balance Sheet Chart

Total Assets

Total Current Liabilities

Good Will

Immunic balance sheet Correlations

Immunic Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Immunic balance sheet Accounts

Also Currently Popular

Additional Tools for Immunic Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 1.0	Cash And Short Term Investments
Common Stock	+ 1.0	Common Stock Total Equity
Cash And Short Term Investments	+ 0.99	Cash
Total Current Assets	+ 0.99	Cash
Total Current Assets	+ 0.97	Total Assets

Cash And Short Term Investments	- 0.99	Net Debt
Cash	- 0.99	Net Debt
Total Current Assets	- 0.98	Net Debt
Net Debt	- 0.95	Total Assets
Net Debt	- 0.94	Total Stockholder Equity
Other Stockholder Equity	- 0.88	Retained Earnings